42 results
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
21 May 10
Discovery Labs Achieves Key Milestone Towards Potential Surfaxin® Approval
12:00am
that Discovery Labs employs in an extensive quality surveillance program to assess drug product quality and stability. These highly sophisticated release … tests monitor drug product quality throughout shelf-life and represent very sensitive methods for detecting changes in quality over time.
Discovery Labs
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
24 Apr 09
Discovery Labs Receives Complete Response from FDA
12:00am
in an extensive quality surveillance program to assess product quality and stability of Surfaxin. These highly sophisticated tests monitor the quality … of Surfaxin at release and through its shelf-life and represent very sensitive methods for detecting changes in product quality and identifying defective
8-K
EX-99.2
WINT
Windtree Therapeutics Inc
7 Aug 07
Discovery Labs Reports Second Quarter 2007 Financial Results
12:00am
. The CMC section of an NDA contains information to demonstrate that the drug product can be manufactured consistently to meet appropriate product quality requirements
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
2 Jul 09
Discovery Labs Reports on Surfaxin End of Review Meeting with FDA
12:00am
sophisticated tests monitor drug product quality at release and through shelf-life and represent very sensitive methods for detecting changes in quality
8-K
EX-10.1
0vv88l28o ofbftoa52m
9 Dec 19
Windtree Therapeutics Completes $26.4 Million Private Placement
5:09pm
8-K
EX-10.3
62rz2
21 Dec 18
Windtree Therapeutics and CVie Therapeutics Announce Merger to Create a Global Acute Care Company Targeting Cardiovascular and Respiratory Diseases
5:28pm
8-K
EX-1.1
vcir1x
24 Mar 21
Entry into a Material Definitive Agreement
5:20pm
8-K
EX-1.1
xviq8xo19bxhz x351
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
S-1/A
EX-1.1
4ybc0fmbfcn4
6 May 20
IPO registration (amended)
5:31pm
8-K
EX-1.1
thgkg 3fosx
24 Apr 23
Entry into a Material Definitive Agreement
4:40pm
424B5
6z4fwex ud
7 Dec 07
Prospectus supplement for primary offering
12:00am
424B5
kk9 o4tp3b
3 Apr 07
Prospectus supplement for primary offering
12:00am